SARS-CoV-2: receptor and co-receptor tropism probability

N Eslami, PS Aghbash, A Shamekh… - Current …, 2022 - Springer
The recent pandemic which arose from China, is caused by a pathogenic virus named
“severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2)”. Its rapid global …

Identification and validation of predictive factors for progression to severe COVID-19 pneumonia by proteomics

B Di, H Jia, OJ Luo, F Lin, K Li, Y Zhang… - Signal transduction and …, 2020 - nature.com
Recent study showed that around 80% of coronavirus disease-19 (COVID-19) patients are
moderate cases who will recover with or without conventional treatment, while the remaining …

A review on the immune responses against novel emerging coronavirus (SARS-CoV-2)

R Lotfi, RN Kalmarzi, SA Roghani - Immunologic research, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by a
newly identified coronavirus called the severe acute respiratory syndrome-coronavirus 2 …

Highlight of immune pathogenic response and hematopathologic effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 infection

Y Liang, ML Wang, CS Chien, AA Yarmishyn… - Frontiers in …, 2020 - frontiersin.org
A sudden outbreak of COVID-19 caused by a novel coronavirus, SARS-CoV-2, in Wuhan,
China in December 2019 quickly grew into a global pandemic, putting at risk not only the …

Inflammatory Response in COVID-19 Depending on the Severity of the Disease and the Vaccination Status

F Trofin, EV Nastase, MF Roșu, AC Bădescu… - International journal of …, 2023 - mdpi.com
The aim of this study was to analyze the serum concentration of interleukin-6 (IL-6), C-
reactive protein (CRP), D-dimer, lactate dehydrogenase (LDH), ferritin, and procalcitonin in …

[HTML][HTML] The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study

J Liu, C Tu, M Zhu, J Wang, C Yang, W Liu, B Xiong - Medicine, 2021 - journals.lww.com
With the surge of newly diagnosed and severe cases of coronavirus disease 2019 (COVID-
19), the death toll is mounting, this study is aimed to explore the prognostic factors of severe …

Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019

E Kowitdamrong, T Puthanakit, W Jantarabenjakul… - PloS one, 2020 - journals.plos.org
Background A greater understanding of the antibody response to SARS-CoV-2 in an
infected population is important for the development of a vaccination. Aim To investigate …

Prediction of COVID-19 patients at high risk of progression to severe disease

Z Dai, D Zeng, D Cui, D Wang, Y Feng, Y Shi… - Frontiers in Public …, 2020 - frontiersin.org
In order to develop a novel scoring model for the prediction of coronavirus disease-19
(COVID-19) patients at high risk of severe disease, we retrospectively studied 419 patients …

Clinical and immunological features of severe and moderate coronavirus disease 2019

G Chen, DI Wu, W Guo, Y Cao… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Since December 2019, an outbreak of coronavirus disease 2019 (COVID-
19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in …

SARS‐CoV‐2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities

GP Delcuve, TM Lakowski, RC Su, TH Beacon… - IUBMB …, 2020 - Wiley Online Library
Abstract SARS‐CoV‐2, the causing agent of the ongoing COVID‐19 pandemic, is a beta‐
coronavirus which has 80% genetic homology with SARS‐CoV, but displays increased …